Safety and Pharmacokinetics of Recombinant Factor XIII Administration in Healthy Volunteers

Clinical trial NCT01848002 · COMPLETED

Trial details

NCT number: NCT01848002
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Congenital FXIII Deficiency Healthy

Start date: 2003-05-01
Primary completion: 2003-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.